Alzheimer's drug shows promising results in trial study

The company is already seeking an accelerated approval from the U.S. Food and Drug Administration, and the agency is expected to decide by early next year.

Related Keywords

Cambridge ,Cambridgeshire ,United Kingdom ,France ,Eli Lilly ,Graig Suvannavejh ,Research Memory Centre ,Claude Pompidou Institute ,Japan Eisai Co ,Drug Administration ,Memory Centre Resources ,Eisai Co ,Biogen Inc ,Alzheimer Association ,Memory Centre ,Mizuho Securities ,Massachusetts Based Biogen ,Indianapolis Based Eli Lilly ,Health ,News ,